Table 4 Summary of model performance predicting future lipid-regulating drug use.

From: Adipose tissue gene expression and longitudinal clinical phenotypes are early biomarkers of lipid-regulating drug usage

Combination

Features

AUC

1

ASCVD

0.722

2

28 Traits including ASCVD (FDR 5%)

0.844

3

15 Genes (FDR 5%)

0.651

4

1212 Genes (p < 0.05)

0.904

5

28 Traits + 1212 Genes

0.919

Back to article page